ZAP70 (Ab-493) Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Target

The ZAP70 (Ab-493) Antibody targets the phosphorylated form of ZAP70, a 70-kDa protein kinase essential for T-cell receptor (TCR) signaling. Phosphorylation at Tyr493 is catalyzed by Lck kinase, which activates ZAP70's enzymatic activity and initiates downstream signaling pathways . The antibody's specificity ensures detection of active ZAP70 in immunological studies.

Key Features

ParameterDetails
TargetPhosphorylated Tyr493 of ZAP70 (70-kDa zeta-associated protein kinase)
Host SpeciesRabbit
IsotypePolyclonal IgG
ReactivityHuman, mouse, rat
ApplicationsWestern blot (WB), immunohistochemistry (IHC), ELISA

Biological Role of ZAP70

ZAP70 is a Syk-family tyrosine kinase primarily expressed in T and NK cells. Its activation is pivotal for TCR-mediated signaling, enabling immune responses to pathogens. Key functions include:

  • TCR Signal Transduction: Binds phosphorylated ITAM motifs on the TCR ζ-chain, recruiting downstream effectors such as LAT, SLP76, and PLCγ1 .

  • T-Cell Development: Critical for thymocyte survival and maturation, particularly CD8+ T-cell differentiation .

  • Disease Implications: Defects in ZAP70 expression or activity correlate with severe combined immunodeficiency (SCID) and chronic lymphocytic leukemia (B-CLL) progression .

Applications in Research

The ZAP70 (Ab-493) Antibody is widely used in immunological studies to monitor T-cell activation and signaling. Example experimental applications include:

Western Blot Analysis

  • Jurkat T-Cell Stimulation: Detects phosphorylated ZAP70 in cells treated with PMA/TPA (200 nM, 10 min) or ATP (5 mM, 1 hr) .

  • Sample Preparation: Lysates from HL60 cells or breast carcinoma tissues are resolved via SDS-PAGE and probed with the antibody (1:5000 dilution) .

Immunohistochemistry

  • Paraffin-Embedded Tissues: Validated for staining ZAP70 in human breast carcinoma and lymphoid tissues (1:50 dilution) .

Experimental Data

  • Western Blot Results: Jurkat cells treated with PMA/TPA show strong ZAP70 pTyr493 signal, confirming activation-dependent phosphorylation .

  • Immunohistochemistry: Positive staining in human breast carcinoma tissues highlights ZAP70's role in tumor immune microenvironments .

Clinical Implications

  • Immunodeficiency: Mutations in ZAP70 lead to SCID, characterized by impaired CD8+ T-cell development and defective TCR signaling .

  • Leukemia: ZAP70 expression in B-CLL correlates with aggressive disease phenotypes and reduced survival .

Product Specs

Form
Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Lead Time
Generally, we can ship the products within 1-3 business days after receiving your order. Delivery time may vary depending on the purchasing method or location. For specific delivery time, please consult your local distributors.
Synonyms
70 kDa zeta associated protein antibody; 70 kDa zeta-associated protein antibody; EC 2.7.10.2 antibody; FLJ17670 antibody; FLJ17679 antibody; Selective T cell defect antibody; SRK antibody; STD antibody; Syk related tyrosine kinase antibody; Syk-related tyrosine kinase antibody; Truncated ZAP kinase antibody; Tyrosine protein kinase ZAP70 antibody; Tyrosine-protein kinase ZAP-70 antibody; TZK antibody; ZAP 70 antibody; ZAP70 antibody; ZAP70_HUMAN antibody; Zeta chain associated protein kinase 70kD antibody; Zeta chain associated protein kinase 70kDa antibody; Zeta chain associated protein kinase 70kDa isoform 1 antibody; Zeta chain associated protein kinase 70kDa isoform 2 antibody; Zeta chain of T cell receptor associated protein kinase 70 antibody; Zeta chain TCR associated protein kinase 70kD antibody; Zeta chain TCR associated protein kinase 70kDa antibody
Target Names
Uniprot No.

Target Background

Function
ZAP70 is a tyrosine kinase that plays a critical role in regulating the adaptive immune response. It governs the motility, adhesion, and cytokine expression of mature T cells, as well as thymocyte development. ZAP70 also contributes to the development and activation of primary B lymphocytes. When antigen-presenting cells (APCs) activate the T cell receptor (TCR), a series of phosphorylation events leads to the recruitment of ZAP70 to the doubly phosphorylated TCR component CD247/CD3Z through the ITAM motif at the plasma membrane. This recruitment serves to localize ZAP70 to the stimulated TCR and relieve its autoinhibited conformation. The release of ZAP70's active conformation is further stabilized by phosphorylation mediated by LCK. Subsequently, ZAP70 phosphorylates at least two essential adapter proteins: LAT and LCP2. In turn, a large number of signaling molecules are recruited, ultimately leading to lymphokine production, T cell proliferation, and differentiation. Furthermore, ZAP70 controls cytoskeleton modifications, adhesion, and mobility of T lymphocytes, ensuring the correct delivery of effectors to the APC. ZAP70 is also required for TCR-CD247/CD3Z internalization and degradation through interaction with the E3 ubiquitin-protein ligase CBL and adapter proteins SLA and SLA2. Thus, ZAP70 regulates both the activation and deactivation of the T cell switch by modulating TCR expression on the T cell surface. During thymocyte development, ZAP70 promotes the survival and cell cycle progression of developing thymocytes before positive selection (when cells are still CD4/CD8 double negative). Additionally, ZAP70-dependent signaling pathways may also contribute to primary B cell formation and activation through the B cell receptor (BCR).
Gene References Into Functions
  1. ZAP-70 was a strong prognostic biomarker for patients with CLL PMID: 29680229
  2. In this article, the authors demonstrated that Natural killer cells can reduce their functional role through downregulation of Syk and Zap70 kinases. PMID: 29263215
  3. These results identify a tight negative feedback loop in which ZAP-70-activated p38 reciprocally phosphorylates ZAP-70 and destabilizes the signaling complex. PMID: 29440413
  4. We have identified a new redox-active motif which is crucial for the regulation of Zap70 stability/activity. We believe that this motif has the potential to become a novel target for the development of therapeutic tools to modulate the expression/activity of kinases. PMID: 28415650
  5. The expression of COBLL1, LPL, and ZAP70 corresponded to patient prognosis and to IGHV mutational status, although not absolutely. When we combined all three markers together and performed the ROC analysis, AUC increased compared to the AUC of individual gene expression. PMID: 27185377
  6. The authors found that ZAP-70 selects its substrates by utilizing an electrostatic mechanism that excludes substrates with positively-charged residues and favors LAT and SLP-76 phosphosites that are surrounded by negatively-charged residues. PMID: 27700984
  7. The data describe the critical early step of directional cell movement toward SDF-1 that ZAP-70 is recruited to the CXCR4 at the leading edge of membrane and consequently modulates lamellipodia/filopodia formation and integrin activation. PMID: 28846922
  8. The study identified the criteria for the design of binders that specifically address either the Syk or the Zap-70 Tandem Src Homology 2 Domains, tSH2. While Syk tSH2 has a rather broad substrate scope, ZAP-70 tSH2 required a proximal arrangement of the phosphotyrosine ligands in a defined strand orientation. PMID: 28767218
  9. ZAP-70 signaling was impaired by cholesterol depletion, further supporting the importance of membrane organization in TCR signaling. PMID: 27384937
  10. We conclude that ZAP70 plays a role for the homing to and/or the survival of ALL cells in the CNS and that ZAP70 may represent a therapeutic target. Furthermore, targeting CCR7/CXCR4 may be particularly promising in treating T-ALL. PMID: 27686375
  11. The aim of this study was to evaluate the expression of ZAP70 changing during disease progression, the intracellular interferon gamma (IFN-gamma) and IL-4 content of T and B lymphocytes and the CLL cell subset (CD5+CD19+) in CLL patients and healthy subjects, and ZAP70 correlation with cytokine production. PMID: 26376785
  12. In this study, authors discovered a cycle of recruitment, activation, and release for Zap70 kinases at phosphorylated T-cell antigen receptors, which turned them into a 'catalytic unit' that amplified antigenic stimuli PMID: 27869819
  13. The histological observations suggested that the patients represent diverse cases of NHL like mature B-cell type, mature T-cell type and high grade diffuse B-cell type NHL. The findings indicate that patients with NHL may also be analyzed for status of PAX5, CD19 and ZAP70, and their transcriptional and post-translational variants for the differential diagnosis of NHL and therapy. PMID: 27748274
  14. Compound heterozygous mutations in ZAP70 gene is associated with leaky severe combined immunodeficiency disorder. PMID: 28124082
  15. The results suggest that genetic polymorphism in the 3' UTR of ZAP-70 is associated with rheumatoid arthritis susceptibility in southern Taiwanese. PMID: 26245723
  16. Cellular studies with ZAP70 showed that multiple lipids bind its C-terminal SH2 domain in a spatiotemporally specific manner and thereby exert exquisite spatiotemporal control over its protein binding and signaling activities in T cells. PMID: 27052731
  17. Whole-exome sequencing performed on five family members revealed two affected siblings to be compound heterozygous for two unique missense mutations in the 70-kD T cell receptor zeta-chain associated protein (ZAP-70). PMID: 26783323
  18. The data suggest that ZO-1, along with CD38 and Zap-70, plays a role in cell cycle regulation in chronic B cell leukemia, and may be used as a prognostic marker in the disease monitoring. PMID: 26306999
  19. A distinct set of proteins interaction partners required for chemokine-directed T cell migration is attracted by phosphotyrosine 571 of ADAP, including ZAP70. PMID: 26246585
  20. Activation of innate immune receptors induces an antiapoptotic signal and proliferation in ZAP-70-positive chronic lymphocytic leukemia dependent on Syk activation. PMID: 26508782
  21. In all, our study demonstrates that miR-631 decreases PCa cell migration and invasion by dampening ZAP70 expression. PMID: 26620225
  22. The differential requirements of ZAP70 and SYK during thymic development. PMID: 26187144
  23. Blockade of CXCR7 suppressed MIF-mediated ERK- and zeta-chain-associated protein kinase (ZAP)-70 activation PMID: 26139098
  24. The kinase activity of ZAP-70 stimulates negative feedback pathways that target Lck and thereby modulate the phosphorylation patterns of the immunoreceptor tyrosine-based activation motifs of t cell receptors. PMID: 25990959
  25. Low ZAP-70 expression is associated with B-cell chronic lymphoid leukemia. PMID: 25743836
  26. We observed decreased CD3 surface expression, reduced ZAP-70 abundance and increased histone H3-acetylation in activated T lymphocytes after 5 minutes of clinorotation and a transient downregulation of CD3 and stable downregulation of IL-2R PMID: 25661802
  27. These findings confirm the role of PTPN22 and CD28 involved in the T cell activation pathway in the development of T1D in Tunisian families. Interestingly, ZAP70 and TCRbeta/CD3z seem to contribute to the susceptibility to the disease in our population. PMID: 25448703
  28. In ZAP-70(+) patients with B-cell chronic lymphocytic leukaemia, the CD4/CD8 ratio was significantly below the norm indicating an active disease process. PMID: 25804237
  29. ZAP-70 and CD 38 positivity were detected 25% and 36%, respectively in Chronic lymphocytic leukemia patients with concordance rate of 56%, which is higher than Western literature. PMID: 24369212
  30. Results provide the first evidence for differential expression of CD27 among CLL prognostic groups, suggest a role for ZAP-70 dependent signaling in CD27 induction and implicate CD27 in cell-cell interactions with the lymphoid tissue microenvironment PMID: 26002513
  31. Novel biosensor ROZA-XL displays a 3-4 times greater dynamic range than its predecessor and possesses a robust baseline FRET value for ZAP-70 PMID: 25735979
  32. Data indicate there was substantial decline in ZAP-70 and biomarker protein levels in Vacutainer cell processing tubes (CPTs)-isolated chronic lymphocytic leukemia (CLL) cells. PMID: 25124785
  33. Data indicate that the decreasing trend in the expression level of TCRzeta chain, ZAP-70 kinase and epsilon Fc Receptors FcvarepsilonRIgamma was significantly associated with disease progression. PMID: 25513989
  34. A specific cysteine residue in the phosphotyrosine-binding pocket of each protein (Cys39 in ZAP-70, Cys206 in Syk) that is necessary for inhibition thiol-reactive compounds, was identified. PMID: 25287889
  35. The corrected mean fluorescence intensity (CorrMFI) represents the most promising method currently available in a routine diagnostic setting for the assessment of ZAP-70 expression in CLL patients. PMID: 24127306
  36. In early stage B-CLL patients, ZAP-70 upregulation is associated with distinct patterns of activation/differentiation stage subset distribution and of cytokine expression in CD4 T lymphocytes. PMID: 24166938
  37. ZAP-70 CpG+223 methylation represents a superior biomarker in risk-stratification of chronic lymphocytic leukemia PMID: 24868078
  38. ZAP-70 enhances the migration of malignant B-cells into the supportive microenvironment found in the bone marrow mainly by enhancing signaling and migration after CXCR4 stimulation. PMID: 24312539
  39. LAT is a modulator of CD3zeta and ZAP-70 tyrosine phosphorylation. PMID: 24204825
  40. Zap70 mutation reducing protein stability demonstrates rate-limiting threshold for Zap70 protein levels exists at which signalling capacity switches from nearly intact to effectively null. PMID: 24164480
  41. Both drugs significantly decreased the expressions of CD5 and ZAP-70. PMID: 23686733
  42. A deficient lipid rafts recruitment of CD3zeta/ZAP-70/Grb2, and these proteins do not merge with GM1 within the lipid rafts. PMID: 23916875
  43. Data indicate that inflammatory cytokine-induced increases in chronic lymphocytic leukemia (CLL) cell adhesion to stromal cells are correlated with ZAP-70 expression and blocked by PI3K inhibitor. PMID: 23981382
  44. Investigated, using the Sequenom MassARRAY platform, polymorphisms of sixteen single-nucleotide polymorphisms (SNPs) belonging to PTPN22, CD28, CTLA-4, and ZAP-70 genes in 76 T1D patients and 162 unrelated healthy controls PMID: 24103478
  45. Expression of ZAP70 in CLL cells increases expression of the NF-kappaB target genes interleukin-1beta, IL6 & IL8 upon BCR triggering. ZAP70 directly amplifies NF-kappaB signaling in CLL cells which could be an underlying mechanism for its poor prognosis. PMID: 24219331
  46. ZAP70 expression in regulatory T cells in allergic rhinitis: effect of immunotherapy. PMID: 23786282
  47. CBAP indeed can function as a novel signaling component within the ZAP70/Vav1/talin complex and plays an important role in regulating chemokine-promoted T-cell trafficking. PMID: 23620790
  48. Evaluated expression of CD74 in chronic lymphocytic leukemia patients. CD74 expression was significantly higher in the CLL group than in controls. There was a positive correlation between CD74 and ZAP70 expression. PMID: 23572149
  49. These results suggest the involvement of the ZAP70 and PTPN6 genes in the genetic component conferring a general susceptibility to Crohn's disease and ulcerative colitis, respectively. PMID: 23406209
  50. Structural basis for activation of ZAP-70 by phosphorylation of the SH2-kinase linker. Autoinhibition of ZAP-70 is fully released upon phosphorylation by Src family kinases. PMID: 23530057

Show More

Hide All

Database Links

HGNC: 12858

OMIM: 176947

KEGG: hsa:7535

STRING: 9606.ENSP00000264972

UniGene: Hs.234569

Involvement In Disease
Immunodeficiency 48 (IMD48); Autoimmune disease, multisystem, infantile-onset, 2 (ADMIO2)
Protein Families
Protein kinase superfamily, Tyr protein kinase family, SYK/ZAP-70 subfamily
Subcellular Location
Cytoplasm. Cell membrane; Peripheral membrane protein.
Tissue Specificity
Expressed in T- and natural killer cells. Also present in early thymocytes and pro/pre B-cells.

Q&A

What is the functional significance of ZAP70 Y493 phosphorylation in T-cell signaling?

Phosphorylation of tyrosine 493 (Y493) in the activation loop of ZAP70's kinase domain is critical for its full catalytic activity. This site serves as a molecular switch that transforms ZAP70 from an inactive to an active state following T-cell receptor (TCR) engagement. Biochemical and functional evidence demonstrates that trans-phosphorylation of Y493 by a Src-family protein tyrosine kinase (primarily Lck) is required for antigen receptor-mediated activation of both calcium and ras signaling pathways .

The importance of Y493 phosphorylation has been confirmed through mutational studies where ZAP70 with Y493F substitution significantly impairs TCR-mediated signaling . Interestingly, ZAP70 can also undergo auto-phosphorylation at this site, though Lck-mediated phosphorylation appears to be the predominant mechanism . This phosphorylation event maintains ZAP70 in its active conformation, preventing it from returning to an autoinhibited state .

How does ZAP70 Y493 phosphorylation differ from other phosphorylation sites in the protein?

ZAP70 contains multiple phosphorylation sites that serve distinct regulatory functions:

Phosphorylation SiteLocationFunctionEffect on Activity
Y493Activation loopRequired for full catalytic activityActivation
Y492Activation loopInhibits catalytic functionInhibition
Y319Interdomain BBinding site for LckActivation
Y315Interdomain BStructural stabilityActivation
Y292Interdomain BRecruitment of E3 ubiquitin ligase c-CblInhibition

Unlike Y492 phosphorylation which inhibits ZAP70 function, Y493 phosphorylation is essential for activating the kinase. Interestingly, inhibition of ZAP70 activity leads to increased phosphorylation of Y493, suggesting a negative feedback mechanism that regulates this site and dampens ZAP70 activation . This complex interplay of phosphorylation events creates a finely tuned system for regulating T-cell activation.

What are the optimal protocols for using ZAP70 (Ab-493) antibody in Western blotting experiments?

For optimal Western blotting results with ZAP70 (Ab-493) antibody, follow these methodological guidelines:

Sample Preparation:

  • Treat cells with appropriate stimulants to induce phosphorylation (e.g., pervanadate [1mM] for 30 minutes or H₂O₂ [2mM] for 2 minutes after serum starvation) .

  • Lyse cells in phosphate buffered saline containing phosphatase inhibitors to preserve phosphorylation status.

  • Load approximately 25μg protein per lane for optimal detection .

Protocol:

  • Use appropriate dilution (1:500-1:1000) of the primary ZAP70 (Ab-493) antibody .

  • Incubate with HRP-conjugated secondary antibody (typically goat anti-rabbit IgG at 1:10000 dilution) .

  • Use 3% BSA or nonfat dry milk in TBST as blocking buffer .

  • Perform detection using standard ECL methods.

Western blot analysis consistently shows a specific band for phosphorylated ZAP70 at approximately 70 kDa when using Jurkat human acute T cell leukemia cell line as a positive control . The antibody's specificity can be verified by comparing samples from untreated cells versus cells stimulated with pervanadate or H₂O₂ .

How should ZAP70 (Ab-493) antibody be applied in immunohistochemistry applications?

For immunohistochemistry applications, the following methodology is recommended:

Protocol:

  • Use formalin-fixed, paraffin-embedded tissue sections.

  • Apply heat-induced epitope retrieval in citrate buffer (pH 6.0).

  • Dilute ZAP70 (Ab-493) antibody at 1:50-1:200 for optimal staining .

  • Incubate at 4°C overnight or at room temperature for 1-2 hours.

  • Apply appropriate detection system based on the host species (typically rabbit).

Application Notes:

  • ZAP70 (Ab-493) antibody has been successfully used to detect endogenous levels of phosphorylated ZAP70 in human breast carcinoma tissue .

  • The antibody shows reactivity across human, mouse, and rat samples, making it versatile for comparative studies .

  • Store the antibody at -20°C for long-term preservation, with aliquoting recommended to avoid repeated freeze-thaw cycles .

How can the ZAP70 (Ab-493) antibody be used to study T-cell activation dynamics?

Using ZAP70 (Ab-493) antibody to study T-cell activation dynamics requires a sophisticated experimental approach:

Methodological Framework:

  • Time-course experiments: Stimulate T-cells with anti-CD3 antibodies or antigen-presenting cells loaded with specific peptides for varying durations (30 seconds to 30 minutes) .

  • Quantitative analysis: Use quantitative Western blotting or flow cytometry to measure the kinetics of Y493 phosphorylation relative to other phosphorylation events.

  • Single-cell analysis: Combine with confocal microscopy and immunofluorescence to examine subcellular localization patterns of activated ZAP70 .

Research has demonstrated that following TCR engagement, Y493 phosphorylation occurs within minutes and can remain elevated for over 10 minutes . This phosphorylation is hierarchical, with Y319 phosphorylation typically preceding Y493 phosphorylation. The binding of Lck to phosphorylated Y319 promotes the activated state of Lck and further facilitates ZAP70 activation through phosphorylation of Y493 .

How can ZAP70 (Ab-493) antibody be utilized in studies of autoimmune disease mechanisms?

ZAP70 (Ab-493) antibody provides a valuable tool for investigating autoimmune disease mechanisms:

Experimental Approaches:

  • Comparative analysis: Examine Y493 phosphorylation levels in T-cells from patients with autoimmune diseases versus healthy controls.

  • Animal models: Use ZAP70 mutant mouse models (e.g., Zap70(AS)) with selectively blockable catalytic activity to analyze how perturbations in ZAP70 function affect autoimmunity development .

  • Mechanistic studies: Combine with other molecular tools to investigate how altered ZAP70 signaling affects downstream pathways.

Research has revealed that both hypoactive and hyperactive ZAP70 can lead to autoimmune diseases through distinct mechanisms . Perturbations in ZAP70 function can overcome tolerance mechanisms by affecting the signaling strength required for negative selection during T-cell development or by altering peripheral T-cell activation thresholds . By using ZAP70 (Ab-493) antibody to monitor the phosphorylation status at Y493, researchers can gain insights into how these mechanisms operate in various autoimmune conditions.

What are the common sources of variability when using ZAP70 (Ab-493) antibody, and how can they be addressed?

Several factors can introduce variability when using ZAP70 (Ab-493) antibody:

Sources of Variability and Solutions:

  • Phosphorylation Instability:

    • Issue: Rapid dephosphorylation of Y493 by phosphatases during sample preparation.

    • Solution: Always include phosphatase inhibitors (e.g., sodium orthovanadate, sodium fluoride) in lysis buffers and maintain samples at 4°C during processing .

  • Stimulation Conditions:

    • Issue: Inconsistent cell stimulation leads to variable phosphorylation.

    • Solution: Standardize stimulation protocols; pervanadate (1mM, 30 minutes) or H₂O₂ (2mM, 2 minutes) treatments provide reliable positive controls .

  • Antibody Specificity:

    • Issue: Cross-reactivity with other phosphorylated tyrosine residues.

    • Solution: Include appropriate negative controls, such as Y493F mutants or samples treated with specific ZAP70 inhibitors like 3-MB-PP1 in ZAP70(AS) cells .

  • Storage Conditions:

    • Issue: Antibody degradation affecting sensitivity and specificity.

    • Solution: Store at -20°C in small aliquots to prevent repeated freeze-thaw cycles; glycerol-based storage buffers (50% glycerol) help maintain antibody stability .

How can researchers distinguish between ZAP70 Y493 phosphorylation and other activation-associated modifications?

Distinguishing between different ZAP70 phosphorylation events requires careful experimental design:

Methodological Approaches:

  • Sequential Immunoprecipitation:

    • First immunoprecipitate with a total ZAP70 antibody, then perform Western blotting with specific phospho-antibodies targeting Y492, Y493, Y319, and other sites to compare their relative abundance .

  • Phosphatase Treatment Controls:

    • Treat duplicate samples with lambda phosphatase prior to immunoblotting to confirm signal specificity for phosphorylated epitopes.

  • Mass Spectrometry Validation:

    • Use liquid chromatography-tandem mass spectrometry (LC-MS/MS) to precisely identify and quantify phosphorylation at specific residues, providing an antibody-independent verification method .

  • Genetic Approaches:

    • Compare signals from wild-type cells with those expressing ZAP70 bearing specific tyrosine-to-phenylalanine mutations (Y493F, Y492F, Y319F) to definitively identify the phosphorylation site being detected .

Research has shown that Y493 phosphorylation can occur even in the absence of ZAP70 catalytic activity, demonstrating that this site can be phosphorylated by other kinases (primarily Lck) and does not strictly require ZAP70 auto-phosphorylation . This distinction is important when interpreting experimental results.

How can ZAP70 (Ab-493) antibody be integrated into single-cell analysis platforms?

Integration of ZAP70 (Ab-493) antibody into single-cell analysis platforms represents a frontier in immunological research:

Advanced Methodologies:

  • Mass Cytometry (CyTOF):

    • Conjugate ZAP70 (Ab-493) antibody with heavy metal isotopes for use in CyTOF workflows.

    • Enables simultaneous detection of Y493 phosphorylation alongside dozens of other cellular markers.

    • Allows identification of rare T-cell subpopulations with distinct ZAP70 activation profiles.

  • Imaging Flow Cytometry:

    • Combine fluorescently-labeled ZAP70 (Ab-493) antibody with subcellular markers.

    • Enables quantification of ZAP70 phosphorylation levels while preserving information about cellular morphology and protein localization .

  • Single-Cell Phospho-Proteomics:

    • Use ZAP70 (Ab-493) antibody in fluorescence-activated cell sorting (FACS) to isolate cells with specific phosphorylation signatures.

    • Subject sorted populations to detailed phospho-proteomic analysis to identify downstream signaling networks.

These techniques reveal the heterogeneity of ZAP70 activation patterns within seemingly homogeneous T-cell populations, providing insights into T-cell functional diversity in health and disease states.

What are the implications of ZAP70 Y493 phosphorylation for the development of immunotherapeutic approaches?

Understanding ZAP70 Y493 phosphorylation has significant implications for immunotherapeutic development:

Therapeutic Considerations:

  • CAR-T Cell Engineering:

    • Modulating ZAP70 Y493 phosphorylation status in chimeric antigen receptor (CAR) T-cells could optimize their activation thresholds and effector functions.

    • ZAP70 (Ab-493) antibody can be used to screen and validate engineered CAR constructs with modified signaling domains.

  • Small Molecule Development:

    • Research using selective ZAP70 inhibitors in animal models demonstrates that T-cell effector functions, including cytolytic activity against target cells, are dependent on ZAP70 catalytic activity .

    • ZAP70 (Ab-493) antibody serves as an essential tool for evaluating the efficacy of novel small molecules targeting ZAP70 signaling in preclinical models.

  • Biomarker Identification:

    • Aberrant ZAP70 Y493 phosphorylation patterns may serve as biomarkers for autoimmune diseases or immunodeficiencies.

    • ZAP70 (Ab-493) antibody enables the development of diagnostic assays to monitor this potential biomarker.

ZAP70 deficiency results in severely impaired immune function, while higher levels of ZAP70 expression are associated with certain B-cell malignancies . Precisely modulating ZAP70 activity through therapeutic intervention could provide new avenues for treating both immunodeficiency and autoimmunity.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.